A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-833)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 135 participants.

Also called NCT02748057

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 135 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02748057
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02748057. Randomized; no masking; primary purpose treatment. Start 2016-05-18 (actual); primary completion 2017-12-11 (actual). Results posted on 2018-12-04.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-833)
Condition
Hypercholesterolemia
Intervention (Drug)
Ezetimibe
Intervention (Drug)
Rosuvastatin
Lead sponsor
Organon and Co (class: industry)

Record details

Record id
cardio:ct-nct02748057
Content hash
71227b1b1889094eb8aa157da2d60f2057ef21570a5a732737ebb191ddfda07b